Early detection, risk stratification, and drug target identification in pulmonary arterial hypertension with plasma proteomics
Early detection, risk stratification, and drug target identification in pulmonary arterial hypertension with plasma proteomics
Pulmonary arterial hypertension is a rare condition that is clinically heterogenous and often diagnosed late in disease progression. Plasma proteomics offers the potential to diagnose earlier, risk-stratify patients, and identify new drug targets.
Learning Objectives
- Pulmonary arterial hypertension as a clinical condition
- Applying proteomics to risk stratification
- Combining proteomics with genome-wide association studies to identify protein quantitative trait loci associated with the condition
Christopher Rhodes, MA, Cantab, PhD
Senior British Heart Foundation Science Fellow
Senior Lecturer
Imperial College London
Martin R. Wilkins
Professor of Clinical Pharmacology
Vice Dean of Research
Faculty of Medicine
Imperial College London
Early detection, risk stratification, and drug target identification in pulmonary arterial hypertension with plasma proteomics
A presentation by Christopher Rhodes, MA, Cantab, PhD, and Martin R. Wilkins
More webinars
WebinarOpening the black box: Building and evaluating machine learning models for proteomics
Machine learning can be a powerful way to extract multivariate signals from high-dimensional proteomics data, but only when models are built and evaluated with rigor. In this on-demand webinar, explore a practical framework for developing predictive and explanatory models, with an emphasis on study design choices that help prevent data leakage, reduce overfitting, and improve reproducibility.
WebinarBeyond the trees: See the bigger biological picture with pathway enrichment analysis
Proteomic data holds enormous potential—but the biology is rarely contained in a single protein. When you’re handed a list of differentially abundant proteins, the next challenge is turning that list into a clear, testable story about mechanisms and processes.
WebinarFinding the signal: Identifying reproducible biomarkers in high-plex proteomics
In biomarker discovery, the challenge is rarely a lack of data. Rather, it is knowing how to separate meaningful biological signal from technical distraction. This webinar focuses on how to use univariate analysis as a practical and powerful entry point for biomarker discovery in high-plex proteomics studies.